Advanced Solid Neoplasms: Clinical Trials

4 trials for Advanced Solid Neoplasms, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

2 withdrawn, 1 active not recruiting, 1 completed. 3 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	3	Withdrawn 2, Completed 1
Phase 2	1	Active not recruiting 1

Follow Advanced Solid Neoplasms: new trials by email Literature Review of Advanced Solid Neoplasms trials Research Report on Advanced Solid Neoplasms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002) Olaparib - Advanced Solid Neoplasms	Phase 2	Active not recruiting	Merck Sharp & Dohme LLC	329	2018-12-12	2026-08-14
A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies [14C]-TAK-659, TAK-659 - Advanced Solid Neoplasms, Lymphoma Neoplasms	Phase 1	Withdrawn	Calithera Biosciences, Inc		2018-05-10	2023-02-08
A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor TAK-659 - Lymphoma, Malignant, Advanced Solid Neoplasms	Phase 1	Withdrawn	Calithera Biosciences, Inc		2018-02-28	2023-02-08
A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors JNJ-64457107 - Advanced Solid Neoplasms	Phase 1	Completed	Janssen Research & Development, LLC	95	2016-09-21	2022-10-06

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Results publications

NIH funding